+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Negative Pressure Wound Therapy Market Size, Share & Trends Analysis Report By End-Use, By Product, By Type (Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Burn Wounds, and Others), By Regional Outlook and Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 220 Pages
  • January 2024
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5928450
The Global Negative Pressure Wound Therapy Market size is expected to reach $3.7 billion by 2030, rising at a market growth of 6.3% CAGR during the forecast period.

Venous leg ulcers are often chronic and challenging to manage due to underlying venous insufficiency. NPWT provides a comprehensive approach to wound care by addressing the specific characteristics of venous leg ulcers, such as high exudate levels and delayed healing. Consequently, the venous leg ulcers segment would acquire nearly 13% of the total market share by 2030. NPWT facilitates granulation tissue formation in the wound bed, a critical aspect of healing venous leg ulcers. By creating a controlled environment, NPWT accelerates healthy tissue formation and contributes to overall wound closure.

Outpatient care and home healthcare enhance accessibility and convenience for patients. NPWT devices that can be utilized in these settings allow patients to receive advanced wound care without prolonged hospital stays, contributing to a more patient-friendly experience. The shift towards outpatient care and home healthcare aligns with a patient-centric approach to healthcare. NPWT, with its focus on promoting patient comfort and improving outcomes, complements this approach and contributes to patient satisfaction. Thus, the market is expanding significantly due to the rapid shift towards outpatient care and home healthcare. Additionally, the escalating rates of diabetes globally contribute to the rising incidence of diabetic foot ulcers. NPWT has proven to be particularly effective in managing diabetic wounds, driving its adoption as a standard of care in many healthcare settings. Infections and complications that progress to more serious health problems are common in diabetic wounds. NPWT helps reduce the risk of complications by creating a sealed environment that minimizes the potential for infections, promoting a faster and more controlled healing process. Therefore, increasing prevalence of diabetes has been a pivotal factor in driving the growth of the market.

Moreover, Disruptions in global supply chains resulted from the pandemic, which impacted the manufacturing and dissemination of medical devices, including NPWT systems and consumables. Manufacturers faced raw material shortages, transportation restrictions, and workforce disruptions. The prolonged nature of the pandemic, with lockdowns and restrictions affecting daily life, contributed to an increase in chronic wounds and pressure injuries. Patients, especially those at higher risk, experienced delays in seeking healthcare, leading to more complex wounds requiring advanced treatments like NPWT. Thus, the COVID-19 pandemic had a moderate effect on the market.

However, the initial cost of NPWT devices can be relatively high. This cost factor may limit the adoption of NPWT, particularly in regions or healthcare systems with budget constraints. The affordability of these devices remains a significant challenge for widespread implementation. The high cost of NPWT devices can influence reimbursement policies and coverage decisions. Payers may hesitate to provide adequate reimbursement for NPWT procedures, limiting the financial support available for healthcare providers and patients. Thus, high cost of NPWT devices can slow down the growth of the market.

By End-Use Analysis

On the basis of end-use, the market is divided into hospitals, homecare, and others. The homecare segment garnered a significant revenue share in the market in 2022. Homecare is a patient-centered healthcare approach that provides treatment in the convenience and comfort of an individual's home. NPWT's application at homecare aligns with this trend, providing patients with a more personalized and less disruptive experience compared to inpatient care. NPWT in homecare settings enables the extended continuity of care. Patients recovering from surgery, managing chronic wounds, or undergoing post-acute care can continue their NPWT treatment seamlessly at home, contributing to better overall outcomes.

By Product Analysis

By product, the market is categorized into conventional NPWT and single-use NPWT. The single-use NPWT segment covered a considerable revenue share in the market in 2022. Single-use NPWT devices are often designed to be compact and portable, offering flexibility in terms of patient mobility. This is particularly advantageous in outpatient settings and home healthcare, where patients can continue their treatment conveniently. Single-use NPWT devices often use advanced dressing materials for optimal performance and comfort. These materials are selected to promote effective negative pressure, manage exudate, and create an environment conducive to wound healing.

By Type Analysis

Based on type, the market is classified into diabetic foot ulcers, venous leg ulcers, pressure ulcers, burn wounds, and others. The diabetic foot ulcers segment acquired a substantial revenue share in the market in 2022. Diabetic foot ulcers are often chronic and complex wounds that require specialized care. NPWT provides a comprehensive approach to wound management by promoting granulation tissue formation, reducing edema, and addressing the specific challenges associated with DFUs. DFUs can lead to severe complications, and in some cases, amputation may be necessary. The use of NPWT in treating diabetic foot ulcers has been associated with reduced amputation rates. This positive outcome benefits patients and contributes to the overall demand for NPWT.

By Regional Analysis

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. The prevalence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, is on the rise in North America. North America has a highly advanced healthcare infrastructure, including advanced medical facilities and a focus on adopting cutting-edge medical technologies. The aging population in North America, particularly in the United States, has led to a higher prevalence of chronic conditions such as diabetes.

List of Key Companies Profiled

  • 3M Company
  • Talley Group Ltd. (Direct Healthcare Group)
  • Smith & Nephew PLC
  • Molnlycke Health Care AB
  • DeRoyal Industries, Inc.
  • ConvaTec Group PLC
  • Cardinal Health, Inc.
  • HARTMANN Group (Paul Hartmann AG)
  • Cork Medical, LLC

Market Report Segmentation

By End-Use
  • Hospitals
  • Homecare
  • Others
By Product
  • Conventional NPWT
  • Single-use NPWT
By Type
  • Pressure Ulcers
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Burn Wounds
  • Others
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Negative Pressure Wound Therapy Market, by End-Use
1.4.2 Global Negative Pressure Wound Therapy Market, by Product
1.4.3 Global Negative Pressure Wound Therapy Market, by Type
1.4.4 Global Negative Pressure Wound Therapy Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Global Negative Pressure Wound Therapy Market, By End-Use
4.1 Global Hospitals Market, By Region
4.2 Global Homecare Market, By Region
4.3 Global Others Market, By Region
Chapter 5. Global Negative Pressure Wound Therapy Market, By Product
5.1 Global Conventional NPWT Market, By Region
5.2 Global Single-use NPWT Market, By Region
Chapter 6. Global Negative Pressure Wound Therapy Market, By Type
6.1 Global Pressure Ulcers Market, By Region
6.2 Global Diabetic Foot Ulcers Market, By Region
6.3 Global Venous Leg Ulcers Market, By Region
6.4 Global Burn Wounds Market, By Region
6.5 Global Others Market, By Region
Chapter 7. Global Negative Pressure Wound Therapy Market, By Region
7.1 North America Negative Pressure Wound Therapy Market
7.1.1 North America Negative Pressure Wound Therapy Market, By End-Use
7.1.1.1 North America Hospitals Market, By Country
7.1.1.2 North America Homecare Market, By Country
7.1.1.3 North America Others Market, By Country
7.1.2 North America Negative Pressure Wound Therapy Market, By Product
7.1.2.1 North America Conventional NPWT Market, By Country
7.1.2.2 North America Single-use NPWT Market, By Country
7.1.3 North America Negative Pressure Wound Therapy Market, By Type
7.1.3.1 North America Pressure Ulcers Market, By Country
7.1.3.2 North America Diabetic Foot Ulcers Market, By Country
7.1.3.3 North America Venous Leg Ulcers Market, By Country
7.1.3.4 North America Burn Wounds Market, By Country
7.1.3.5 North America Others Market, By Country
7.1.4 North America Negative Pressure Wound Therapy Market, By Country
7.1.4.1 US Negative Pressure Wound Therapy Market
7.1.4.1.1 US Negative Pressure Wound Therapy Market, By End-Use
7.1.4.1.2 US Negative Pressure Wound Therapy Market, By Product
7.1.4.1.3 US Negative Pressure Wound Therapy Market, By Type
7.1.4.2 Canada Negative Pressure Wound Therapy Market
7.1.4.2.1 Canada Negative Pressure Wound Therapy Market, By End-Use
7.1.4.2.2 Canada Negative Pressure Wound Therapy Market, By Product
7.1.4.2.3 Canada Negative Pressure Wound Therapy Market, By Type
7.1.4.3 Mexico Negative Pressure Wound Therapy Market
7.1.4.3.1 Mexico Negative Pressure Wound Therapy Market, By End-Use
7.1.4.3.2 Mexico Negative Pressure Wound Therapy Market, By Product
7.1.4.3.3 Mexico Negative Pressure Wound Therapy Market, By Type
7.1.4.4 Rest of North America Negative Pressure Wound Therapy Market
7.1.4.4.1 Rest of North America Negative Pressure Wound Therapy Market, By End-Use
7.1.4.4.2 Rest of North America Negative Pressure Wound Therapy Market, By Product
7.1.4.4.3 Rest of North America Negative Pressure Wound Therapy Market, By Type
7.2 Europe Negative Pressure Wound Therapy Market
7.2.1 Europe Negative Pressure Wound Therapy Market, By End-Use
7.2.1.1 Europe Hospitals Market, By Country
7.2.1.2 Europe Homecare Market, By Country
7.2.1.3 Europe Others Market, By Country
7.2.2 Europe Negative Pressure Wound Therapy Market, By Product
7.2.2.1 Europe Conventional NPWT Market, By Country
7.2.2.2 Europe Single-use NPWT Market, By Country
7.2.3 Europe Negative Pressure Wound Therapy Market, By Type
7.2.3.1 Europe Pressure Ulcers Market, By Country
7.2.3.2 Europe Diabetic Foot Ulcers Market, By Country
7.2.3.3 Europe Venous Leg Ulcers Market, By Country
7.2.3.4 Europe Burn Wounds Market, By Country
7.2.3.5 Europe Others Market, By Country
7.2.4 Europe Negative Pressure Wound Therapy Market, By Country
7.2.4.1 Germany Negative Pressure Wound Therapy Market
7.2.4.1.1 Germany Negative Pressure Wound Therapy Market, By End-Use
7.2.4.1.2 Germany Negative Pressure Wound Therapy Market, By Product
7.2.4.1.3 Germany Negative Pressure Wound Therapy Market, By Type
7.2.4.2 UK Negative Pressure Wound Therapy Market
7.2.4.2.1 UK Negative Pressure Wound Therapy Market, By End-Use
7.2.4.2.2 UK Negative Pressure Wound Therapy Market, By Product
7.2.4.2.3 UK Negative Pressure Wound Therapy Market, By Type
7.2.4.3 France Negative Pressure Wound Therapy Market
7.2.4.3.1 France Negative Pressure Wound Therapy Market, By End-Use
7.2.4.3.2 France Negative Pressure Wound Therapy Market, By Product
7.2.4.3.3 France Negative Pressure Wound Therapy Market, By Type
7.2.4.4 Russia Negative Pressure Wound Therapy Market
7.2.4.4.1 Russia Negative Pressure Wound Therapy Market, By End-Use
7.2.4.4.2 Russia Negative Pressure Wound Therapy Market, By Product
7.2.4.4.3 Russia Negative Pressure Wound Therapy Market, By Type
7.2.4.5 Spain Negative Pressure Wound Therapy Market
7.2.4.5.1 Spain Negative Pressure Wound Therapy Market, By End-Use
7.2.4.5.2 Spain Negative Pressure Wound Therapy Market, By Product
7.2.4.5.3 Spain Negative Pressure Wound Therapy Market, By Type
7.2.4.6 Italy Negative Pressure Wound Therapy Market
7.2.4.6.1 Italy Negative Pressure Wound Therapy Market, By End-Use
7.2.4.6.2 Italy Negative Pressure Wound Therapy Market, By Product
7.2.4.6.3 Italy Negative Pressure Wound Therapy Market, By Type
7.2.4.7 Rest of Europe Negative Pressure Wound Therapy Market
7.2.4.7.1 Rest of Europe Negative Pressure Wound Therapy Market, By End-Use
7.2.4.7.2 Rest of Europe Negative Pressure Wound Therapy Market, By Product
7.2.4.7.3 Rest of Europe Negative Pressure Wound Therapy Market, By Type
7.3 Asia Pacific Negative Pressure Wound Therapy Market
7.3.1 Asia Pacific Negative Pressure Wound Therapy Market, By End-Use
7.3.1.1 Asia Pacific Hospitals Market, By Country
7.3.1.2 Asia Pacific Homecare Market, By Country
7.3.1.3 Asia Pacific Others Market, By Country
7.3.2 Asia Pacific Negative Pressure Wound Therapy Market, By Product
7.3.2.1 Asia Pacific Conventional NPWT Market, By Country
7.3.2.2 Asia Pacific Single-use NPWT Market, By Country
7.3.3 Asia Pacific Negative Pressure Wound Therapy Market, By Type
7.3.3.1 Asia Pacific Pressure Ulcers Market, By Country
7.3.3.2 Asia Pacific Diabetic Foot Ulcers Market, By Country
7.3.3.3 Asia Pacific Venous Leg Ulcers Market, By Country
7.3.3.4 Asia Pacific Burn Wounds Market, By Country
7.3.3.5 Asia Pacific Others Market, By Country
7.3.4 Asia Pacific Negative Pressure Wound Therapy Market, By Country
7.3.4.1 China Negative Pressure Wound Therapy Market
7.3.4.1.1 China Negative Pressure Wound Therapy Market, By End-Use
7.3.4.1.2 China Negative Pressure Wound Therapy Market, By Product
7.3.4.1.3 China Negative Pressure Wound Therapy Market, By Type
7.3.4.2 Japan Negative Pressure Wound Therapy Market
7.3.4.2.1 Japan Negative Pressure Wound Therapy Market, By End-Use
7.3.4.2.2 Japan Negative Pressure Wound Therapy Market, By Product
7.3.4.2.3 Japan Negative Pressure Wound Therapy Market, By Type
7.3.4.3 India Negative Pressure Wound Therapy Market
7.3.4.3.1 India Negative Pressure Wound Therapy Market, By End-Use
7.3.4.3.2 India Negative Pressure Wound Therapy Market, By Product
7.3.4.3.3 India Negative Pressure Wound Therapy Market, By Type
7.3.4.4 South Korea Negative Pressure Wound Therapy Market
7.3.4.4.1 South Korea Negative Pressure Wound Therapy Market, By End-Use
7.3.4.4.2 South Korea Negative Pressure Wound Therapy Market, By Product
7.3.4.4.3 South Korea Negative Pressure Wound Therapy Market, By Type
7.3.4.5 Singapore Negative Pressure Wound Therapy Market
7.3.4.5.1 Singapore Negative Pressure Wound Therapy Market, By End-Use
7.3.4.5.2 Singapore Negative Pressure Wound Therapy Market, By Product
7.3.4.5.3 Singapore Negative Pressure Wound Therapy Market, By Type
7.3.4.6 Malaysia Negative Pressure Wound Therapy Market
7.3.4.6.1 Malaysia Negative Pressure Wound Therapy Market, By End-Use
7.3.4.6.2 Malaysia Negative Pressure Wound Therapy Market, By Product
7.3.4.6.3 Malaysia Negative Pressure Wound Therapy Market, By Type
7.3.4.7 Rest of Asia Pacific Negative Pressure Wound Therapy Market
7.3.4.7.1 Rest of Asia Pacific Negative Pressure Wound Therapy Market, By End-Use
7.3.4.7.2 Rest of Asia Pacific Negative Pressure Wound Therapy Market, By Product
7.3.4.7.3 Rest of Asia Pacific Negative Pressure Wound Therapy Market, By Type
7.4 LAMEA Negative Pressure Wound Therapy Market
7.4.1 LAMEA Negative Pressure Wound Therapy Market, By End-Use
7.4.1.1 LAMEA Hospitals Market, By Country
7.4.1.2 LAMEA Homecare Market, By Country
7.4.1.3 LAMEA Others Market, By Country
7.4.2 LAMEA Negative Pressure Wound Therapy Market, By Product
7.4.2.1 LAMEA Conventional NPWT Market, By Country
7.4.2.2 LAMEA Single-use NPWT Market, By Country
7.4.3 LAMEA Negative Pressure Wound Therapy Market, By Type
7.4.3.1 LAMEA Pressure Ulcers Market, By Country
7.4.3.2 LAMEA Diabetic Foot Ulcers Market, By Country
7.4.3.3 LAMEA Venous Leg Ulcers Market, By Country
7.4.3.4 LAMEA Burn Wounds Market, By Country
7.4.3.5 LAMEA Others Market, By Country
7.4.4 LAMEA Negative Pressure Wound Therapy Market, By Country
7.4.4.1 Brazil Negative Pressure Wound Therapy Market
7.4.4.1.1 Brazil Negative Pressure Wound Therapy Market, By End-Use
7.4.4.1.2 Brazil Negative Pressure Wound Therapy Market, By Product
7.4.4.1.3 Brazil Negative Pressure Wound Therapy Market, By Type
7.4.4.2 Argentina Negative Pressure Wound Therapy Market
7.4.4.2.1 Argentina Negative Pressure Wound Therapy Market, By End-Use
7.4.4.2.2 Argentina Negative Pressure Wound Therapy Market, By Product
7.4.4.2.3 Argentina Negative Pressure Wound Therapy Market, By Type
7.4.4.3 UAE Negative Pressure Wound Therapy Market
7.4.4.3.1 UAE Negative Pressure Wound Therapy Market, By End-Use
7.4.4.3.2 UAE Negative Pressure Wound Therapy Market, By Product
7.4.4.3.3 UAE Negative Pressure Wound Therapy Market, By Type
7.4.4.4 Saudi Arabia Negative Pressure Wound Therapy Market
7.4.4.4.1 Saudi Arabia Negative Pressure Wound Therapy Market, By End-Use
7.4.4.4.2 Saudi Arabia Negative Pressure Wound Therapy Market, By Product
7.4.4.4.3 Saudi Arabia Negative Pressure Wound Therapy Market, By Type
7.4.4.5 South Africa Negative Pressure Wound Therapy Market
7.4.4.5.1 South Africa Negative Pressure Wound Therapy Market, By End-Use
7.4.4.5.2 South Africa Negative Pressure Wound Therapy Market, By Product
7.4.4.5.3 South Africa Negative Pressure Wound Therapy Market, By Type
7.4.4.6 Nigeria Negative Pressure Wound Therapy Market
7.4.4.6.1 Nigeria Negative Pressure Wound Therapy Market, By End-Use
7.4.4.6.2 Nigeria Negative Pressure Wound Therapy Market, By Product
7.4.4.6.3 Nigeria Negative Pressure Wound Therapy Market, By Type
7.4.4.7 Rest of LAMEA Negative Pressure Wound Therapy Market
7.4.4.7.1 Rest of LAMEA Negative Pressure Wound Therapy Market, By End-Use
7.4.4.7.2 Rest of LAMEA Negative Pressure Wound Therapy Market, By Product
7.4.4.7.3 Rest of LAMEA Negative Pressure Wound Therapy Market, By Type
Chapter 8. Company Profiles
8.1 DeRoyal Industries, Inc.
8.1.1 Company Overview
8.2 Cork Medical, LLC
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Product Launches and Product Expansions:
8.3 3M Company
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Talley Group Ltd. (Direct Healthcare Group)
8.4.1 Company Overview
8.5 Smith & Nephew PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional and Segmental Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.6 SWOT Analysis
8.6 Molnlycke Health Care AB
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Product Launches and Product Expansions:
8.6.3 SWOT Analysis
8.7 ConvaTec Group PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 SWOT Analysis
8.8 Cardinal Health, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 SWOT Analysis
8.9 HARTMANN Group (Paul Hartmann AG)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Acquisition and Mergers:
8.9.6 SWOT Analysis
Chapter 9. Winning Imperatives of Negative Pressure Wound Therapy Market

Companies Mentioned

  • 3M Company
  • Talley Group Ltd. (Direct Healthcare Group)
  • Smith & Nephew PLC
  • Molnlycke Health Care AB
  • DeRoyal Industries, Inc.
  • ConvaTec Group PLC
  • Cardinal Health, Inc.
  • HARTMANN Group (Paul Hartmann AG)
  • Cork Medical, LLC

Methodology

Loading
LOADING...